Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol

Peer Review reports

Original Submission
9 Jun 2017	Submitted	Original manuscript
2 Aug 2017	Author responded	Author comments - Sheeba Thomas
Resubmission - Version 2
2 Aug 2017	Submitted	Manuscript version 2
14 Nov 2017	Author responded	Author comments - Sheeba Thomas
Resubmission - Version 3
14 Nov 2017	Submitted	Manuscript version 3
Publishing
5 Feb 2018	Editorially accepted
13 Feb 2018	Article published	10.1186/s12885-018-4094-2

Back to article page